Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC) Meeting Abstract


Authors: Bendell, J. C.; Kim, T. W.; Goh, B. C.; Wallin, J.; Oh, D. Y.; Han, S. W.; Lee, C. B.; Hellmann, M. D.; Desai, J.; Lewin, J. H.; Solomon, B. J.; Chow, L. Q. M.; Miller, W. H.; Gainor, J. F.; Flaherty, K.; Infante, J. R.; Das-Thakur, M.; Foster, P.; Cha, E.; Bang, Y. J.
Abstract Title: Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC)
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 171s
Language: English
ACCESSION: WOS:000404665404220
DOI: 10.1200/JCO.2016.34.15_suppl.3502
PROVIDER: wos
Notes: Meeting Abstract: 3502 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann